nodes	percent_of_prediction	percent_of_DWPC	metapath
Tubocurarine—ACHE—Irinotecan—pancreatic cancer	0.76	1	CbGbCtD
Tubocurarine—HTR3A—enteric nervous system—pancreatic cancer	0.133	0.753	CbGeAlD
Tubocurarine—ACHE—islet of Langerhans—pancreatic cancer	0.0143	0.0813	CbGeAlD
Tubocurarine—HTR3A—islet of Langerhans—pancreatic cancer	0.0127	0.072	CbGeAlD
Tubocurarine—SLC22A2—digestive system—pancreatic cancer	0.00884	0.0502	CbGeAlD
Tubocurarine—HTR3A—digestive system—pancreatic cancer	0.00762	0.0432	CbGeAlD
Tubocurarine—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—pancreatic cancer	0.00014	0.00218	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—CNR2—pancreatic cancer	0.000139	0.00216	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—GLP1R—pancreatic cancer	0.000139	0.00216	CbGpPWpGaD
Tubocurarine—CHRND—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000136	0.00212	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—CCKAR—pancreatic cancer	0.000136	0.00212	CbGpPWpGaD
Tubocurarine—CHRM2—Regulation of Actin Cytoskeleton—PIK3CG—pancreatic cancer	0.000136	0.00211	CbGpPWpGaD
Tubocurarine—CHRM2—Regulation of Actin Cytoskeleton—EGF—pancreatic cancer	0.000134	0.00209	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatic cancer	0.000131	0.00203	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—SHH—pancreatic cancer	0.000124	0.00193	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	0.000124	0.00193	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PRLHR—pancreatic cancer	0.000124	0.00193	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—IAPP—pancreatic cancer	0.000123	0.00191	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PRSS1—pancreatic cancer	0.000121	0.00188	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—pancreatic cancer	0.00012	0.00187	CbGpPWpGaD
Tubocurarine—CHRM2—Regulation of Actin Cytoskeleton—PIK3CD—pancreatic cancer	0.000119	0.00185	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—PTHLH—pancreatic cancer	0.000118	0.00183	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—PTCH1—pancreatic cancer	0.000118	0.00183	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000117	0.00183	CbGpPWpGaD
Tubocurarine—CHRNA1—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000116	0.0018	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—SSTR3—pancreatic cancer	0.000116	0.0018	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	0.000115	0.00179	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GDI1—pancreatic cancer	0.000114	0.00177	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GDI2—pancreatic cancer	0.000114	0.00177	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	0.000112	0.00175	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	0.000111	0.00173	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—SSTR1—pancreatic cancer	0.000111	0.00173	CbGpPWpGaD
Tubocurarine—CHRNA2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.00011	0.00171	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000109	0.0017	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—PPY—pancreatic cancer	0.000109	0.0017	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	0.000108	0.00169	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—SST—pancreatic cancer	0.000108	0.00168	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—SSTR2—pancreatic cancer	0.000107	0.00166	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—SSTR3—pancreatic cancer	0.000105	0.00164	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—ARG2—pancreatic cancer	0.000105	0.00163	CbGpPWpGaD
Tubocurarine—CHRND—Neuronal System—HRAS—pancreatic cancer	0.000105	0.00163	CbGpPWpGaD
Tubocurarine—CHRM2—Regulation of Actin Cytoskeleton—PIK3CB—pancreatic cancer	0.000104	0.00162	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—CCKBR—pancreatic cancer	0.000103	0.00161	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—SSTR1—pancreatic cancer	0.000101	0.00157	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	0.0001	0.00156	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—GCG—pancreatic cancer	9.95e-05	0.00155	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—CNR1—pancreatic cancer	9.94e-05	0.00155	CbGpPWpGaD
Tubocurarine—ACHE—Phospholipid metabolism—PIK3CA—pancreatic cancer	9.91e-05	0.00154	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PPY—pancreatic cancer	9.9e-05	0.00154	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	9.79e-05	0.00152	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—SSTR2—pancreatic cancer	9.72e-05	0.00151	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PRSS1—pancreatic cancer	9.65e-05	0.0015	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	9.62e-05	0.0015	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—GCG—pancreatic cancer	9.6e-05	0.00149	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—CCKBR—pancreatic cancer	9.38e-05	0.00146	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	9.21e-05	0.00143	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—TYMP—pancreatic cancer	9.17e-05	0.00143	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—AGTR1—pancreatic cancer	9.16e-05	0.00143	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	9e-05	0.0014	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PRSS1—pancreatic cancer	8.99e-05	0.0014	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	8.98e-05	0.0014	CbGpPWpGaD
Tubocurarine—CHRNA1—Neuronal System—HRAS—pancreatic cancer	8.89e-05	0.00138	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—GAST—pancreatic cancer	8.89e-05	0.00138	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	8.88e-05	0.00138	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	8.81e-05	0.00137	CbGpPWpGaD
Tubocurarine—CHRNA2—Neuronal System—HRAS—pancreatic cancer	8.44e-05	0.00131	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—SCT—pancreatic cancer	8.42e-05	0.00131	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	8.39e-05	0.0013	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—ARG2—pancreatic cancer	8.36e-05	0.0013	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	8.32e-05	0.00129	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—GAST—pancreatic cancer	8.07e-05	0.00126	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—CCK—pancreatic cancer	8.04e-05	0.00125	CbGpPWpGaD
Tubocurarine—CHRM2—Regulation of Actin Cytoskeleton—NRAS—pancreatic cancer	8.01e-05	0.00125	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—CNR2—pancreatic cancer	7.83e-05	0.00122	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—GLP1R—pancreatic cancer	7.83e-05	0.00122	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	7.82e-05	0.00122	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—ARG2—pancreatic cancer	7.79e-05	0.00121	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—CCKAR—pancreatic cancer	7.7e-05	0.0012	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—SCT—pancreatic cancer	7.65e-05	0.00119	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	7.64e-05	0.00119	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	7.57e-05	0.00118	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—GLP1R—pancreatic cancer	7.4e-05	0.00115	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	7.39e-05	0.00115	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PRLHR—pancreatic cancer	7.31e-05	0.00114	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—TYMP—pancreatic cancer	7.31e-05	0.00114	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—CCK—pancreatic cancer	7.3e-05	0.00114	CbGpPWpGaD
Tubocurarine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—pancreatic cancer	7.3e-05	0.00114	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—DPYD—pancreatic cancer	7.28e-05	0.00113	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—CNR2—pancreatic cancer	7.11e-05	0.00111	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—GLP1R—pancreatic cancer	7.11e-05	0.00111	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—CCKAR—pancreatic cancer	7e-05	0.00109	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—IAPP—pancreatic cancer	6.94e-05	0.00108	CbGpPWpGaD
Tubocurarine—CHRM2—G alpha (i) signalling events—CXCL8—pancreatic cancer	6.93e-05	0.00108	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—SLC2A2—pancreatic cancer	6.9e-05	0.00107	CbGpPWpGaD
Tubocurarine—CHRM2—Regulation of Actin Cytoskeleton—KRAS—pancreatic cancer	6.89e-05	0.00107	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ZNRF3—pancreatic cancer	6.88e-05	0.00107	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ACVR1B—pancreatic cancer	6.88e-05	0.00107	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	6.83e-05	0.00106	CbGpPWpGaD
Tubocurarine—ACHE—Transmission across Chemical Synapses—HRAS—pancreatic cancer	6.82e-05	0.00106	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—TYMP—pancreatic cancer	6.81e-05	0.00106	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—TNF—pancreatic cancer	6.7e-05	0.00104	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—PTHLH—pancreatic cancer	6.66e-05	0.00104	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	6.59e-05	0.00103	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—SHH—pancreatic cancer	6.38e-05	0.000992	CbGpPWpGaD
Tubocurarine—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—pancreatic cancer	6.33e-05	0.000985	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—IAPP—pancreatic cancer	6.3e-05	0.00098	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	6.24e-05	0.000971	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—DTX1—pancreatic cancer	6.22e-05	0.000968	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—SSTR3—pancreatic cancer	6.22e-05	0.000968	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—SST—pancreatic cancer	6.09e-05	0.000947	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PTHLH—pancreatic cancer	6.05e-05	0.000941	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PTCH1—pancreatic cancer	6.05e-05	0.000941	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	6.01e-05	0.000934	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—SSTR1—pancreatic cancer	5.96e-05	0.000928	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—GLP1R—pancreatic cancer	5.89e-05	0.000917	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PPY—pancreatic cancer	5.85e-05	0.00091	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—DPYD—pancreatic cancer	5.8e-05	0.000902	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—SSTR2—pancreatic cancer	5.74e-05	0.000893	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—CNR1—pancreatic cancer	5.62e-05	0.000874	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CCKBR—pancreatic cancer	5.54e-05	0.000862	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—SST—pancreatic cancer	5.53e-05	0.00086	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	5.51e-05	0.000858	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—SLC2A2—pancreatic cancer	5.5e-05	0.000856	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GLP1R—pancreatic cancer	5.49e-05	0.000854	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	5.43e-05	0.000845	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—GCG—pancreatic cancer	5.43e-05	0.000844	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—DPYD—pancreatic cancer	5.4e-05	0.000841	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CD44—pancreatic cancer	5.35e-05	0.000832	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.24e-05	0.000814	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—MMP2—pancreatic cancer	5.23e-05	0.000814	CbGpPWpGaD
Tubocurarine—ACHE—Neuronal System—HRAS—pancreatic cancer	5.22e-05	0.000812	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GLI1—pancreatic cancer	5.21e-05	0.000811	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—DTX4—pancreatic cancer	5.21e-05	0.000811	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.19e-05	0.000807	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—AGTR1—pancreatic cancer	5.18e-05	0.000806	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—SLC2A2—pancreatic cancer	5.13e-05	0.000798	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—GCG—pancreatic cancer	5.13e-05	0.000797	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—CNR1—pancreatic cancer	5.1e-05	0.000794	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—NRP1—pancreatic cancer	5.07e-05	0.000789	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PPP2R5B—pancreatic cancer	5.07e-05	0.000789	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmission across Chemical Synapses—HRAS—pancreatic cancer	5.06e-05	0.000787	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—GCG—pancreatic cancer	4.93e-05	0.000767	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—HEY2—pancreatic cancer	4.88e-05	0.000759	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—STK11—pancreatic cancer	4.82e-05	0.00075	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GAST—pancreatic cancer	4.77e-05	0.000742	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—AGTR1—pancreatic cancer	4.7e-05	0.000732	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.52e-05	0.000704	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—SCT—pancreatic cancer	4.52e-05	0.000703	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—HEY1—pancreatic cancer	4.52e-05	0.000703	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—CXCL8—pancreatic cancer	4.35e-05	0.000676	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CCK—pancreatic cancer	4.31e-05	0.000671	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CD44—pancreatic cancer	4.26e-05	0.000663	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CNR2—pancreatic cancer	4.2e-05	0.000654	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GLP1R—pancreatic cancer	4.2e-05	0.000654	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—CXCL8—pancreatic cancer	4.2e-05	0.000653	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—HRAS—pancreatic cancer	4.16e-05	0.000647	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—TYMS—pancreatic cancer	4.15e-05	0.000645	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CCKAR—pancreatic cancer	4.13e-05	0.000643	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—GCG—pancreatic cancer	4.08e-05	0.000635	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—CTNNB1—pancreatic cancer	4.01e-05	0.000624	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—JAG2—pancreatic cancer	4.01e-05	0.000623	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CD44—pancreatic cancer	3.97e-05	0.000618	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—MEN1—pancreatic cancer	3.95e-05	0.000614	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—HRAS—pancreatic cancer	3.88e-05	0.000603	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—STK11—pancreatic cancer	3.84e-05	0.000597	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GCG—pancreatic cancer	3.81e-05	0.000592	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—SHH—pancreatic cancer	3.77e-05	0.000586	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—NOTCH4—pancreatic cancer	3.74e-05	0.000583	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—IAPP—pancreatic cancer	3.72e-05	0.000579	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—STK11—pancreatic cancer	3.58e-05	0.000557	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PTCH1—pancreatic cancer	3.57e-05	0.000556	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PTHLH—pancreatic cancer	3.57e-05	0.000556	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—APOE—pancreatic cancer	3.37e-05	0.000525	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—TYMS—pancreatic cancer	3.3e-05	0.000514	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—SST—pancreatic cancer	3.27e-05	0.000508	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—PIK3CG—pancreatic cancer	3.22e-05	0.000501	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—JAG1—pancreatic cancer	3.2e-05	0.000497	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.19e-05	0.000497	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—NOTCH3—pancreatic cancer	3.18e-05	0.000495	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—TYMS—pancreatic cancer	3.08e-05	0.000479	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PIK3CG—pancreatic cancer	3.04e-05	0.000473	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CNR1—pancreatic cancer	3.01e-05	0.000469	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PPARG—pancreatic cancer	2.94e-05	0.000457	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PIK3CG—pancreatic cancer	2.93e-05	0.000455	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GCG—pancreatic cancer	2.91e-05	0.000453	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.83e-05	0.000441	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—AGTR1—pancreatic cancer	2.78e-05	0.000432	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—STK11—pancreatic cancer	2.74e-05	0.000426	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—APOE—pancreatic cancer	2.69e-05	0.000418	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PIK3CD—pancreatic cancer	2.67e-05	0.000416	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PIK3CD—pancreatic cancer	2.57e-05	0.0004	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—APOE—pancreatic cancer	2.5e-05	0.00039	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.47e-05	0.000384	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PIK3CG—pancreatic cancer	2.42e-05	0.000377	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—SMAD4—pancreatic cancer	2.4e-05	0.000373	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—CXCL8—pancreatic cancer	2.37e-05	0.000369	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—HES1—pancreatic cancer	2.34e-05	0.000364	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PPARG—pancreatic cancer	2.34e-05	0.000364	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PIK3CB—pancreatic cancer	2.33e-05	0.000363	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PTGS2—pancreatic cancer	2.31e-05	0.000359	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PIK3CG—pancreatic cancer	2.26e-05	0.000352	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PIK3CB—pancreatic cancer	2.24e-05	0.000349	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PPARG—pancreatic cancer	2.18e-05	0.000339	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—CXCL8—pancreatic cancer	2.15e-05	0.000335	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PIK3CD—pancreatic cancer	2.13e-05	0.000332	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—TERT—pancreatic cancer	2.05e-05	0.000319	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PTEN—pancreatic cancer	2.01e-05	0.000313	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PIK3CD—pancreatic cancer	1.99e-05	0.000309	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—HIF1A—pancreatic cancer	1.96e-05	0.000305	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—TSC2—pancreatic cancer	1.96e-05	0.000304	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—APOE—pancreatic cancer	1.92e-05	0.000298	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—KDR—pancreatic cancer	1.88e-05	0.000292	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PIK3CB—pancreatic cancer	1.86e-05	0.000289	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PTGS2—pancreatic cancer	1.84e-05	0.000286	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—NFKBIA—pancreatic cancer	1.78e-05	0.000278	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—NOTCH1—pancreatic cancer	1.77e-05	0.000275	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PIK3CB—pancreatic cancer	1.73e-05	0.000269	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PIK3CG—pancreatic cancer	1.73e-05	0.000269	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—NRAS—pancreatic cancer	1.73e-05	0.000269	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PTGS2—pancreatic cancer	1.72e-05	0.000267	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—EGF—pancreatic cancer	1.71e-05	0.000266	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PTEN—pancreatic cancer	1.61e-05	0.00025	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—EGFR—pancreatic cancer	1.57e-05	0.000245	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PIK3CD—pancreatic cancer	1.52e-05	0.000236	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.51e-05	0.000234	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PTEN—pancreatic cancer	1.5e-05	0.000233	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—KRAS—pancreatic cancer	1.49e-05	0.000231	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PIK3CA—pancreatic cancer	1.42e-05	0.000221	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PIK3CA—pancreatic cancer	1.37e-05	0.000213	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PIK3CB—pancreatic cancer	1.32e-05	0.000206	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CXCL8—pancreatic cancer	1.27e-05	0.000198	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—HRAS—pancreatic cancer	1.26e-05	0.000197	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—AKT1—pancreatic cancer	1.23e-05	0.000191	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CASP3—pancreatic cancer	1.22e-05	0.00019	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	1.19e-05	0.000184	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	1.17e-05	0.000183	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—AKT1—pancreatic cancer	1.16e-05	0.000181	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	1.15e-05	0.000179	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	1.14e-05	0.000178	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PIK3CA—pancreatic cancer	1.13e-05	0.000176	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	1.12e-05	0.000174	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—SRC—pancreatic cancer	1.06e-05	0.000165	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PIK3CA—pancreatic cancer	1.06e-05	0.000164	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	1.03e-05	0.000161	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	1.02e-05	0.000159	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	1.02e-05	0.000159	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—MYC—pancreatic cancer	9.51e-06	0.000148	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	9.49e-06	0.000148	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	9.3e-06	0.000145	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—AKT1—pancreatic cancer	9.25e-06	0.000144	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	8.79e-06	0.000137	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—AKT1—pancreatic cancer	8.62e-06	0.000134	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	8.07e-06	0.000126	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—TP53—pancreatic cancer	7.81e-06	0.000122	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	7.47e-06	0.000116	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	6.6e-06	0.000103	CbGpPWpGaD
